Vasoactive effects and free radical generation by .beta.-amyloid peptides
US6140309A · kind A · utility
2Cited by
16References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 12, 1996 |
| Grant date | Oct 31, 2000 |
| Priority date | — |
| Expiry date | Mar 12, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is disclosed for treating and preventing diseases, wherein at least one of the causes of the disease is .beta.-amyloid peptide induced change in free radical production resulting in vascular endothelial dysfunction and vasoactivity, by antagonizing vascular free radicals in excess of functional equilibrium.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.